The aim of this post hoc analysis was to assess, whether carrying the MTNR1B rs10830963/G risk allele has any effect on the initiation of AIT treatment modality in GDM in a pre-pregnancy BMI-dependent manner. This evidence concerns the gene MTNR1B and gestational diabetes.